Verismo Therapeutics
Clinical trials sponsored by Verismo Therapeutics, explained in plain language.
-
First patients to receive experimental 'Living Drug' for tough cancers
Disease control Recruiting nowThis is a first-in-human safety study testing a single dose of an experimental cell therapy called SynKIR-110. It is for adults with advanced ovarian cancer, bile duct cancer, or mesothelioma that has come back after prior treatment. Doctors will collect a patient's own immune ce…
Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New 'Living Drug' trial offers hope for lymphoma patients out of options
Disease control Recruiting nowThis is a first-in-human study testing the safety and early effectiveness of a new cell therapy called SynKIR-310. It is for adults with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior treatments, including other CAR-T therapies. The main goa…
Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC